US Healthcare Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Healthcare Journal.

Press releases published on September 9, 2026

Sep. 9, 2026

Persephone Biosciences Celebrates First Birthday of Bloom and Thrive Synbiotics, with More Than 1.5 Million Doses Manufactured

Indeterminate GlobeNewswire

Sep. 9, 2026

UF Health Collaborates with R1 on AI-Powered Revenue Cycle Transformation with Phare OS

Indeterminate GlobeNewswire

Sep. 9, 2026

Weight Watchers Appoints Stephen Bye as Chief Executive Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Electra Therapeutics Appoints Chris Clark, CFA, to Chief Financial Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Context Therapeutics Announces First Patient Dosed in Phase 1 Trial of CT-202

Indeterminate GlobeNewswire

Sep. 9, 2026

Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

CRB Names Helga Margrethe Salling Chief Growth Officer

Indeterminate GlobeNewswire

Sep. 9, 2026

Fractyl Health to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

Sep. 9, 2026

Autolus Therapeutics Announces FDA RMAT Designation Granted to Obe-cel for the Treatment of Systemic Lupus Erythematosus and Lupus Nephritis

Indeterminate GlobeNewswire

Sep. 9, 2026

Onco360® Has Been Selected as Part of an Ultra-Narrow Specialty Pharmacy Network for MIMRYLO™ (rusfertide)

Indeterminate GlobeNewswire

Sep. 9, 2026

Kura Oncology Launches Caspian Therapeutics with $50 Million Financing to Advance Menin Inhibition as a Potential Disease-Modifying Approach for Diabetes

Indeterminate GlobeNewswire

Sep. 9, 2026

Beeline Medicines Announces Positive Topline Results from Global Phase 2 Study of Afimetoran in Systemic Lupus Erythematosus

Indeterminate GlobeNewswire

Sep. 9, 2026

Cocrystal Pharma Announces Last Subject Dosed in Phase 1b Human Challenge Study Evaluating CDI-988 for Norovirus Prevention and Treatment

Indeterminate GlobeNewswire

Sep. 9, 2026

Broncos Country, This One’s for You: Breckenridge Distillery Kicks Off Another Season with the Denver Broncos and a Limited-Edition Whiskey Collection Honoring “The Drive”

Indeterminate GlobeNewswire

Sep. 9, 2026

ABBYY Study Finds Business Leaders Disagree on Who Has Ultimate Responsibility When AI Goes Wrong

Indeterminate GlobeNewswire

Sep. 9, 2026

Eledon Pharmaceuticals Announces Presentation at the International Congress of The Transplantation Society

Indeterminate GlobeNewswire

Sep. 9, 2026

Actuate Announces Promising Preclinical Data Showing Synergistic Activity of Elraglusib in Combination with RAS Inhibitors Zoldonrasib and Daraxonrasib

Indeterminate GlobeNewswire

Sep. 9, 2026

MapLight Therapeutics to Participate in Upcoming Investor Conference

Indeterminate GlobeNewswire

Sep. 9, 2026

Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Indeterminate GlobeNewswire

Sep. 9, 2026

Fate Therapeutics Announces Encore Clinical Data Presentation of FT819 Off-the-Shelf CAR T-Cell Product Candidate at the CCR – West 2026 Meeting

Indeterminate GlobeNewswire